Your session is about to expire
← Back to Search
Aerobic Exercise Training (AET) for Interstitial Lung Disease
Study Summary
This trial is to test if aerobic exercise is safe and helpful for patients with interstitial lung disease, a disease where the lungs can't take in enough oxygen. In an uncontrolled study, we saw that patients who did aerobic exercise had better cardiorespiratory function, could do more physical work, and had a better quality of life. So far, aerobic exercise seems safe and plausible for helping patients with ILD.
- Interstitial Lung Disease
- Interstitial Pneumonitis
- Idiopathic Pulmonary Fibrosis
- Desquamative Interstitial Pneumonia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this study meant for young adults or can elderly patients participate?
"The minimum age requirement for this clinical trial is 21 years old. The maximum age an individual can be and still participate in the study is 80 years old."
Are patients being accepted into this clinical trial at this time?
"Yes, the most recent update on clinicaltrials.gov shows that this trial is still searching for participants. The 60 patients needed for the study will be recruited from 3 hospitals or medical clinics."
How often do people experience negative side effects from AET?
"Although there is safety data for AET, it is only from Phase 2 trials. This means that while we know it's safe, we don't yet have evidence to support its efficacy. Consequently, our team at Power has rated the safety of AET as a 2."
Share this study with friends
Copy Link
Messenger